InsiderTrades.com logo

MRKR Insider Trading

Insider Ownership Percentage: 5.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Marker Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Marker Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Marker Therapeutics Share Price & Price History

Current Price: $1.55
Price Change: ▼ Price Decrease of -0.029 (-1.84%)
As of 07/10/2026 10:59 AM ET

This chart shows the closing price history over time for MRKR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Marker Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2024Enterprise Associates 16 NewMajor ShareholderBuy554,250$3.20$1,773,600.001,625,678View SEC Filing Icon  
12/23/2024Steve ElmsDirectorBuy11,085$3.20$35,472.00325,370View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Marker Therapeutics (NASDAQ:MRKR)

22.39% of Marker Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MRKR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Marker Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Renaissance Technologies LLC175,294$0.23M0.0%+41.8%1.052%Search for SEC Filing on Google Icon
2/18/2026NewEdge Advisors LLC149,000$0.22M0.0%N/A0.894%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd58,041$86K0.0%+166.6%0.348%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.94,421$0.14M0.0%+16.5%0.566%Search for SEC Filing on Google Icon
2/12/2026Jane Street Group LLC40,518$60K0.0%N/A0.243%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC123,650$0.18M0.0%+16.4%0.742%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC83,247$0.12M0.0%+41.7%0.499%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC130,344$0.19M0.0%+35.3%0.782%Search for SEC Filing on Google Icon
1/30/2026Boyer Financial Services Inc.36,817$57K0.1%N/A0.221%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC28,329$25K0.0%N/A0.219%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP36,540$33K0.0%N/A0.282%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC21,800$33K0.0%N/A0.193%Search for SEC Filing on Google Icon
5/16/2025Alyeska Investment Group L.P.261,777$0.32M0.0%-71.4%2.314%Search for SEC Filing on Google Icon
2/17/2025NEA Management Company LLC1,625,678$5.06M0.3%+51.7%15.179%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC16,108$50K0.0%N/A0.150%Search for SEC Filing on Google Icon
2/17/2025Alyeska Investment Group L.P.915,591$2.85M0.0%N/A8.549%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp54,156$0.17M0.0%+66.9%0.506%Search for SEC Filing on Google Icon
2/14/2025Blue Owl Capital Holdings LP554,250$1.72M0.4%N/A5.175%Search for SEC Filing on Google Icon
2/12/2025Aisling Capital Management LP325,370$1.01M0.4%+3.5%3.038%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC79,730$0.25M0.0%N/A0.744%Search for SEC Filing on Google Icon
11/19/2024Invst LLC20,000$56K0.0%N/A0.224%Search for SEC Filing on Google Icon
8/7/2024Wedbush Securities Inc.69,500$0.38M0.0%+52.7%0.779%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC11,000$60K0.0%+1,000.0%0.124%Search for SEC Filing on Google Icon
10/12/2023Matrix Asset Advisors Inc. NY15,000$68K0.0%-62.5%0.170%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC20,472$63K0.0%N/A0.233%Search for SEC Filing on Google Icon
7/18/2023Matrix Asset Advisors Inc. NY40,000$0.12M0.0%+60.0%0.455%Search for SEC Filing on Google Icon
5/17/2023Long Focus Capital Management LLC146,100$0.10M0.0%-90.0%1.660%Search for SEC Filing on Google Icon
5/12/2023Long Focus Capital Management LLC68,400$49K0.0%-95.3%0.777%Search for SEC Filing on Google Icon
5/9/2023Aisling Capital Management LP314,286$0.22M0.1%-90.0%3.571%Search for SEC Filing on Google Icon
5/9/2023AR Asset Management Inc.40,700$29K0.0%N/A0.463%Search for SEC Filing on Google Icon
1/19/2023Matrix Asset Advisors Inc. NY250,000$68K0.0%-37.5%0.299%Search for SEC Filing on Google Icon
11/15/2022Long Focus Capital Management LLC1,461,000$0.54M0.1%-40.0%1.748%Search for SEC Filing on Google Icon
10/25/2022Raymond James & Associates94,000$35K0.0%N/A0.112%Search for SEC Filing on Google Icon
10/24/2022Matrix Asset Advisors Inc. NY400,000$0.15M0.0%+60.0%0.478%Search for SEC Filing on Google Icon
7/15/2022Matrix Asset Advisors Inc. NY250,000$83K0.0%+66.7%0.299%Search for SEC Filing on Google Icon
5/10/2022AR Asset Management Inc.279,000$0.12M0.0%+290.2%0.336%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Marker Therapeutics logo
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
Read More on Marker Therapeutics

Today's Range

Now: $1.55
Low: $1.56
High: $1.59

50 Day Range

MA: $1.44
Low: $1.31
High: $1.68

52 Week Range

Now: $1.55
Low: $0.81
High: $4.07

Volume

7,735 shs

Average Volume

187,234 shs

Market Capitalization

$25.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45

Who are the company insiders with the largest holdings of Marker Therapeutics?

Marker Therapeutics' top insider shareholders include:
  1. John Robert Wilson (Director)
  2. Juan Vera (Insider)
  3. Enterprise Associates 16 New (Major Shareholder)
  4. Peter L Hoang (CEO)
  5. Steve Elms (Director)
  6. Norman David Eansor (Director)
  7. Frederick Gerald Wasserman (Director)
  8. Paul Edward Walker (Major Shareholder)
  9. Peter L Hoang (Insider)
Learn More about top insider investors at Marker Therapeutics.

Marker Therapeutics Active Insiders

Juan Vera
Juan Vera (Age 46)
Insider